6505--Amiodarone HCL Tablets

The solicitation requires offerors to submit a fully approved subcontracting plan in accordance with Public Law 95‑507, FAR 52.219‑9 and VAAR 852.219‑70 for any contract valued over $900,000. Offerors must develop dollar and percentage goals for each base‑year and option period, justify any goal that is lower than the VA‑suggested target or lower than the prior year’s achievement, and provide a detailed methodology for goal development. The plan must identify potential sources using specific websites, organizations, or events (general responses will be rejected), state whether indirect costs are included, and separate goals for large‑ and small‑business subcontracting. A commercial plan (company‑wide or division‑wide) must be submitted, showing projected subcontract spend, total sales, and the proportion of subcontracting dollars relative to annual sales, with all required FAR clauses incorporated by reference. In addition, offerors must furnish comprehensive manufacturing information for each product category, including the name, address, and FDA Establishment Identification (FEI) number of the facility that performs the final manufacturing, sterilization, packaging, or repackaging, and certify compliance with current Good Manufacturing Practices (cGMP). If the offeror is a distributor rather than the manufacturer, a Letter of Commitment from the manufacturer confirming sufficient supply is required. The solicitation also mandates identification of the subcontracting program administrator, contract administration and sales‑report points of contact, authorized negotiators, and SAM/UEI, DUNS, and TIN identifiers for verification. All submissions must adhere to the referenced FAR provisions and be signed and returned as directed.

Notice ID

d01b3663a3004a00b98884c35742d949

Solicitation Number

36E79726R0014

NAICS Code

325412

Classification Code

6505